Amneal Pharmaceuticals, Inc. (AMRX): Total Assets
$3.68B
As of 2025-12-31
$3.78B
As of 2026-06-30
-1.1%
3-year compound annual growth
-1.7%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $3.68B | +5.1% | 2026-02-27, Balance as of period end |
| 2024-12-31 | $3.50B | +0.8% | 2026-02-27, Balance as of period end |
| 2023-12-31 | $3.47B | -8.6% | 2025-02-28, Balance as of period end |
| 2022-12-31 | $3.80B | -3.6% | 2024-03-14, Balance as of period end |
| 2021-12-31 | $3.94B | -1.7% | 2023-03-03, Balance as of period end |
| 2020-12-31 | $4.01B | +9.3% | 2022-03-01, Balance as of period end |
| 2019-12-31 | $3.67B | -15.8% | 2021-03-01, Balance as of period end |
| 2018-12-31 | $4.35B | +224.4% | 2020-03-02, Balance as of period end |
| 2017-12-31 | $1.34B | n/a | 2019-03-01, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $3.68B | +5.1% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $7.88B | +7.0% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $7.59B | +8.7% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $4.97B | +17.1% |
| Royalty Pharma plc (RPRX) | 2025-12-31 | $19.62B | +7.7% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $3.35B | -15.5% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $8.54B | -11.5% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $11.66B | -2.9% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $13.36B | +5.9% |
Compare AMRX, UTHR, BMRN, ALNY side by side · Screen every company in Pharmaceutical Preparations ↗